187 related articles for article (PubMed ID: 12417543)
1. Paradoxical effect of sibutramine on autonomic cardiovascular regulation.
Birkenfeld AL; Schroeder C; Boschmann M; Tank J; Franke G; Luft FC; Biaggioni I; Sharma AM; Jordan J
Circulation; 2002 Nov; 106(19):2459-65. PubMed ID: 12417543
[TBL] [Abstract][Full Text] [Related]
2. Paradoxical effect of sibutramine on autonomic cardiovascular regulation in obese hypertensive patients--sibutramine and blood pressure.
Birkenfeld AL; Schroeder C; Pischon T; Tank J; Luft FC; Sharma AM; Jordan J
Clin Auton Res; 2005 Jun; 15(3):200-6. PubMed ID: 15944869
[TBL] [Abstract][Full Text] [Related]
3. Influence of sibutramine treatment on sympathetic vasomotor tone in obese subjects.
Heusser K; Tank J; Diedrich A; Engeli S; Klaua S; Krüger N; Strauss A; Stoffels G; Luft FC; Jordan J
Clin Pharmacol Ther; 2006 May; 79(5):500-8. PubMed ID: 16678551
[TBL] [Abstract][Full Text] [Related]
4. Influence of Sibutramine on blood pressure: evidence from placebo-controlled trials.
Jordan J; Scholze J; Matiba B; Wirth A; Hauner H; Sharma AM
Int J Obes (Lond); 2005 May; 29(5):509-16. PubMed ID: 15685250
[TBL] [Abstract][Full Text] [Related]
5. Selective norepinephrine reuptake inhibition as a human model of orthostatic intolerance.
Schroeder C; Tank J; Boschmann M; Diedrich A; Sharma AM; Biaggioni I; Luft FC; Jordan J
Circulation; 2002 Jan; 105(3):347-53. PubMed ID: 11804991
[TBL] [Abstract][Full Text] [Related]
6. Selective impairment in sympathetic vasomotor control with norepinephrine transporter inhibition.
Tank J; Schroeder C; Diedrich A; Szczech E; Haertter S; Sharma AM; Luft FC; Jordan J
Circulation; 2003 Jun; 107(23):2949-54. PubMed ID: 12796139
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
Sramek JJ; Leibowitz MT; Weinstein SP; Rowe ED; Mendel CM; Levy B; McMahon FG; Mullican WS; Toth PD; Cutler NR
J Hum Hypertens; 2002 Jan; 16(1):13-9. PubMed ID: 11840225
[TBL] [Abstract][Full Text] [Related]
8. Autonomic cardiovascular function and baroreflex sensitivity in patients with cervical dystonia receiving treatment with botulinum toxin type A.
Tiple D; Strano S; Colosimo C; Fabbrini G; Calcagnini G; Prencipe M; Berardelli A
J Neurol; 2008 Jun; 255(6):843-7. PubMed ID: 18458860
[TBL] [Abstract][Full Text] [Related]
9. Effect of beta-blockade on baroreflex sensitivity and cardiovascular autonomic function tests in patients with coronary artery disease.
Airaksinen KE; Niemelä MJ; Huikuri HV
Eur Heart J; 1994 Nov; 15(11):1482-5. PubMed ID: 7835362
[TBL] [Abstract][Full Text] [Related]
10. Influence of St John's wort on catecholamine turnover and cardiovascular regulation in humans.
Schroeder C; Tank J; Goldstein DS; Stoeter M; Haertter S; Luft FC; Jordan J
Clin Pharmacol Ther; 2004 Nov; 76(5):480-9. PubMed ID: 15536462
[TBL] [Abstract][Full Text] [Related]
11. Effects of hydrophilic and lipophilic beta-blockers on heart rate variability and baroreflex sensitivity in normal subjects.
Pitzalis MV; Mastropasqua F; Massari F; Forleo C; Passantino A; Colombo R; Totaro P; Rizzon P
Pacing Clin Electrophysiol; 1998 Mar; 21(3):559-67. PubMed ID: 9558688
[TBL] [Abstract][Full Text] [Related]
12. Hormonal influences on cardiovascular norepinephrine transporter responses in healthy women.
Moldovanova I; Schroeder C; Jacob G; Hiemke C; Diedrich A; Luft FC; Jordan J
Hypertension; 2008 Apr; 51(4):1203-9. PubMed ID: 18259012
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacological therapy of obesity].
Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
[TBL] [Abstract][Full Text] [Related]
14. Phenotypical evidence for a gender difference in cardiac norepinephrine transporter function.
Schroeder C; Adams F; Boschmann M; Tank J; Haertter S; Diedrich A; Biaggioni I; Luft FC; Jordan J
Am J Physiol Regul Integr Comp Physiol; 2004 May; 286(5):R851-6. PubMed ID: 14726430
[TBL] [Abstract][Full Text] [Related]
15. Sympathetic cardiac influence and arterial blood pressure instability.
Formes KJ; Wray DW; O-Yurvati AH; Weiss MS; Shi X
Auton Neurosci; 2005 Mar; 118(1-2):116-24. PubMed ID: 15795185
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular indices of peripheral and central sympathetic activation.
Schächinger H; Weinbacher M; Kiss A; Ritz R; Langewitz W
Psychosom Med; 2001; 63(5):788-96. PubMed ID: 11573027
[TBL] [Abstract][Full Text] [Related]
17. Influences of norepinephrine transporter function on the distribution of sympathetic activity in humans.
Mayer AF; Schroeder C; Heusser K; Tank J; Diedrich A; Schmieder RE; Luft FC; Jordan J
Hypertension; 2006 Jul; 48(1):120-6. PubMed ID: 16717144
[TBL] [Abstract][Full Text] [Related]
18. Age dependency of cardiovascular autonomic responses to head-up tilt in healthy subjects.
Laitinen T; Niskanen L; Geelen G; Länsimies E; Hartikainen J
J Appl Physiol (1985); 2004 Jun; 96(6):2333-40. PubMed ID: 14766788
[TBL] [Abstract][Full Text] [Related]
19. Norepinephrine transporter inhibition prevents tilt-induced pre-syncope.
Schroeder C; Birkenfeld AL; Mayer AF; Tank J; Diedrich A; Luft FC; Jordan J
J Am Coll Cardiol; 2006 Aug; 48(3):516-22. PubMed ID: 16875978
[TBL] [Abstract][Full Text] [Related]
20. Preserved Autonomic Cardiovascular Regulation With Cardiac Pacemaker Inhibition: A Crossover Trial Using High-Fidelity Cardiovascular Phenotyping.
Heusser K; Tank J; Brinkmann J; Schroeder C; May M; Großhennig A; Wenzel D; Diedrich A; Sweep FC; Mehling H; Luft FC; Jordan J
J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26764413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
